期刊文献+

下调Smoothened基因抑制乳腺癌干细胞生长的相关机制 被引量:2

Down-regulation of Smoothened gene expression inhibits proliferation of breast cancer stem cells
原文传递
导出
摘要 目的利用短发夹RNA(shRNA)下调Smoothened(SMO)基因的表达,研究SMO对乳腺癌干细胞增殖的影响。方法设计针对人SMO基因的shRNA,转染人乳腺癌MCF-7细胞系,G418筛选出稳定下调SMO基因的细胞株。体外:活细胞计数试剂盒(CCK8)检测细胞增殖的变化,流式细胞仪检测CIM4+/CD24-乳腺癌干细胞比例,悬浮球培养检测乳腺球形成的能力,Westernblot检测SMO、GLIl及Oct4的表达。体内:每3天检测各组裸鼠成瘤情况,免疫组织化学SP法检测SMO的表达,Westernblot检测SMO、GLIl及Oct4蛋白的表达。结果21d后筛选出稳定下调SMO基因的MCF-7细胞。CCK8结果显示下调SMO基因可以抑制乳腺癌MCF-7细胞的增殖。流式细胞仪显示下调SMO基因后,CD44+/CD24-细胞和乳腺癌干细胞球形成的比例明显降低。下调后裸鼠的肿瘤生长速度下降。免疫组织化学检测显示阴性对照组中SMO阳性表达比例为5/5,SMO.shRNA组阳性比例为2/5。两组肿瘤组织中SMO的蛋白表达水平分别为0.72±0.17和0.21±0.09,GLIl的蛋白表达水平分别为1.21±0.21和0.47±0.12,Oct4的蛋白表达水平分别为0.83±0.13和0.25±0.07。SMO、GLI-1和Oct4在SMO—shRNA组中的表达明显低于阴性对照组(P〈0.05)。结论下调SMO基因可以抑制乳腺癌干细胞的增殖。 Objective To investigate the influence of down-regulating Smoothened (SMO) gene expression through short hairpin RNA (shRNA) on the proliferation of breast cancer stem cells. Methods Human SMO shRNA was designed, synthesized chemically, and transfected into MCF-7 cells to down- regulate SMO gene. By using G418, stable cells with down-regulated SMO were selected. In vitro proliferation of these cells was measured by CCK8 assay. The proportion of CD44 +/CD24- cells was detected by flow cytometry and the mammospheres formation was determined by suspension sphere culture. The expression of SMO, GLI1 and Oct4 was detected by Western blot. In vivo, the volume of tumor was measured every 3 days and the expression of SMO, GLI1 and Oct4 detected by Western blot. Results In vitro, the cells were transfected with SMO-shRNA and selected by G418 after 21 days. SMO-shRNA effectively down-regulated the expression of SMO gene and protein, and inhibited the proliferation of MCF-7 and markedly reduced the proportion of CIM4+/CD24- cells and mammospheres. In vivo, SMO-shRNA treatment of MCF-7 significantly inhibited the volume of tumor. The positive rate of SMO in negative control and SMO-shRNA group was 5/5 and 2/5, respectively. The expression of SMO, GLI1 and Oct4 in different groups were 0. 72±0. 17 and 0. 21± 0. 09, 1.21± 0. 21 and 0. 47 ± 0. 12,0. 83 ± 0. 13 and 0. 25 ± 0. 07. SMO, GLI1 and Oct4 down-regulation significantly suppressed at protein levels ( P 〈 0. 05 ). Conclusion The shRNA by chemical synthesis can effectively down-regulate SMO gene expression and inhibit the proliferation of breast cancer stem cells.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2013年第4期262-266,共5页 Chinese Journal of Pathology
基金 国家自然科学基金(81272430)
关键词 乳腺肿瘤 肿瘤干细胞 RNA 小分子干扰 细胞系 肿瘤 Breast neoplasms Neoplastic stem cells RNA, small interfering Cell line,tumor
  • 相关文献

参考文献14

  • 1Han ME, Lee YS, Baek SY, et al. Hedgehog signaling regulatesthe survival of gastric cancer cells by regulating the expression ofBcl-2. Int J Mol Sci, 2009,10(7) : 3033-3043.
  • 2Jiang J, Hui CC. Hedgehog signaling in development and cancer.Dev Cell, 2008, 15(6) ; 801-812.
  • 3Visbal AP, LaMarca HL,Villanueva H,et al. Altereddifferentiation and paracrine stimulation of mammary epithelial cellproliferation by conditionally activated Smoothened. Dev Biol,2011,352(1) : 116-127.
  • 4Svard J, Heby-Henricson K, Persson-Lek M, et al. Geneticelimination of suppressor of fused reveals an essential repressorfunction in the mammalian Hedgehog signaling pathway. Dev Cell,2006,10(2) : 187-197.
  • 5Lauth M,Bergstrom A,Shimokawa T,et al. Inhibition of GLI-mediated transcription and tumor cell growth by small-moleculeantagonists. Proc Natl Acad Sci USA, 2007,104 ( 20) : 8455-8460.
  • 6Clarke MF, Fuller M. Stem cells and cancer: two faces of eve.Cell, 2006, 124(6): 1111-1115.
  • 7Moraes RC, Zhang X, Harrington N,et al. Constitutive activationof smoothened ( SMO) in mammary glands of transgenic mice leadsto increased proliferation, altered differentiation and ductaldysplasia. Development, 2007,134(6) : 1231-1242.
  • 8Dierks C,Grbic J, Zirlik K, et al. Essential role of stromallyinduced hedgehog signaling in B-cell malignancies. Nat Med,2007,13(8): 944-951.
  • 9Zhao C, Chen A, Jamieson CH, et al. Hedgehog signalling isessential for maintenance of cancer stem cells in myeloidleukaemia. Nature, 2009,458(7239) :776-779.
  • 10Hirotsu M,Setoguchi T,Sasaki H, et al. Smoothened as a newtherapeutic target for human osteosarcoma. Mol Cancer, 2010, 9:5.

同被引文献35

  • 1张长松,李克.Hedgehog信号途径与肿瘤[J].中华肿瘤防治杂志,2006,13(13):1031-1034. 被引量:6
  • 2李连宏,王喜梅,谢丰培,等.乳腺干细胞调控与癌变[M].北京:人民卫生出版社,2009.
  • 3Li L, Xiao B, Tong I-I, et al. Regulation of breast cancer tumori- genesis and metastasis by miRNAs [ J ]. Expert Rev Proteomics, 2012,9(6) :615 -25.
  • 4Jin Y, Mao J, Wang H, et al. Enhanced tumorigenesis and lym7 phatic metastasis of CD133 hepatocarcinoma ascites syngeneic cell lines mediated by JNK signaling pathway in vitro and in vivo [J]. Biomed Pharmacother, 2013,67(4) :337 -45.
  • 5Shigdar S, Qian C, Lv L, et aL The use of sensitive chemical an- tibodies for diagnosis: detection of low levels of EpCAM in breast cancer[J]. PLoS One, 2013,8(2) :e57613.
  • 6Man J, Song B, Shi Y, et al. ShRNA targeting Notchl sensitizes breast cancer stem cell to paclitaxel[ J]. Int J Biochem Cell Biol, 2013,45(6) :1064 -73.
  • 7Shigdar S; Qiao L, Zhou S, et al. RNA aptamers targeting cancer stem cell marker CD133 [ J]. Cancer Lett, 2013,330 ( 1 ) : 84 -95.
  • 8Caterson E J, Caterxon S A. Regeneration in medicine: a plastic surgeons "Taid" of disease, stem cells and a possible future [ J ]. Birth Defects Res C Embryo Today, 2008,84 (4) :322 - 34.
  • 9Stoltz J F, Bensoussan D, Decor V, et al. Cell and tissue engi- neering and clinical applications: an overview [ J ]. Biomed Mater Eng, 2006,16 (4 Suppl) : $3 - 18.
  • 10Diaz-Flores L Jr, Madrid J F, Gutirrez R, et al. Adult stem cell and transit-amplifying cell location [ J ]. Histol Histopathiol, 2006,21 (9) :995 - 1027.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部